Downgrade Dr Lal PathLabs to ‘reduce’ with TP at Rs 2,333

DLPL stock has significantly outperformed its peers and the broader market since the start of the pandemic. Since mid-Feb 2020 (when fear pandemic started), the stock is up 106% against a Nifty return of 18%.

from The Financial Express https://ift.tt/3mZfMeR
https://ift.tt/eA8V8J Nomura